In a human study in which MT-1 and MT-2 protein expression was investigated in the brains of three deceased MS patients and two controls, both active and inactive lesions revealed elevated immunoreactivity of MT-1 and MT-2 in all MS cellular infiltrates with a similar expression pattern to those observed in the EAE model [82]. The gene discussed is MT1A; the disease is myeloid sarcoma.